Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
2.510
-0.050 (-1.95%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $23.55 million as of July 24, 2026. Its market cap has decreased by -91.21% in one year.
Market Cap
23.55M
Enterprise Value
-1.26M
1-Year Change
-91.21%
Ranking
Category
Stock Price
$2.51
ChartMarket Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $23.55M, a decrease of -86.21%. That is a compound annual growth rate of -78.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 23.55M | -41.63% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 27.96M |
| IGC Pharma | 26.74M |
| Evaxion | 26.27M |
| Polyrizon | 26.02M |
| Plus Therapeutics | 26.02M |
| Barinthus Biotherapeutics | 25.44M |
| NeuroSense Therapeutics | 23.33M |
| Skye Bioscience | 22.84M |